INSP
Inspire Medical Systems, Inc.
+0.88 (+1.21%)73.63USD142K成交股數2.1B市值16.3本益比(近四季)2.4股價營收比-7.6%營收年增(近四季)2026-11-02下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 201M-0% | 205M-15% | 225M+10% | 217M+11% | 201M+23% | 240M+56% | 203M+34% | 196M+53% | 164M | 153M | 151M | 128M |
| 營業成本 | 29.1M | 27.7M | 31.8M | 34.7M | 30.7M | 36.0M | 32.4M | 29.8M | 24.8M | 24.4M | 24.3M | 19.9M |
| 毛利 | 171M+0% | 177M-13% | 193M+13% | 182M+10% | 171M+23% | 204M+58% | 171M+35% | 166M+54% | 139M | 129M | 127M | 108M |
| 毛利率 | 85.5% | 86.5% | 85.8% | 84.0% | 84.7% | 85.0% | 84.1% | 84.8% | 84.9% | 84.1% | 83.9% | 84.4% |
| 研發費用 | 24.7M | 25.8M | 24.2M | 26.2M | 27.8M | 30.3M | 26.1M | 28.9M | 28.9M | 29.1M | 30.8M | 25.5M |
| 銷售管理費用 | 147M | 152M | 159M | 160M | 144M | 142M | 130M | 132M | 126M | 113M | 113M | 102M |
| 營業利益 | −514K-65% | −1.1M-104% | 9.6M-33% | −3.3M-165% | −1.5M-90% | 31.9M-337% | 14.3M-186% | 5.1M-126% | −15.2M | −13.5M | −16.6M | −19.5M |
| 營業利益率 | -0.3% | -0.5% | 4.3% | -1.5% | -0.7% | 13.3% | 7.0% | 2.6% | -9.3% | -8.8% | -11.0% | -15.2% |
| 稅後淨利 | 314K-90% | −11.3M-132% | 9.9M-46% | −3.6M-137% | 3.0M-130% | 35.2M-512% | 18.5M-255% | 9.8M-163% | −10.0M | −8.5M | −12.0M | −15.4M |
| 淨利率 | 0.2% | -5.5% | 4.4% | -1.7% | 1.5% | 14.7% | 9.1% | 5.0% | -6.1% | -5.6% | -7.9% | -12.1% |
| 稀釋 EPS | 0.01-90% | -0.39-133% | 0.34-43% | -0.12-138% | 0.10-129% | 1.17-503% | 0.60-246% | 0.32-160% | -0.34 | -0.29 | -0.41 | -0.53 |
| 稀釋股數 | 28.9M | 28.7M | 29.6M | 29.5M | 30.3M | 30.5M | 30.6M | 30.4M | 29.6M | 29.4M | 29.2M | 29.1M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 128M | 98.9M | 113M | 107M | 53.9M | 150M | 148M | 188M | 175M | 330M | 467M | 442M |
| 應收帳款 | 103M | 105M | 108M | 138M | 92.6M | 93.1M | 89.7M | 79.7M | 72.3M | 71.5M | 63.5M | 59.8M |
| 存貨 | 170M | 166M | 142M | 122M | 99.7M | 80.1M | 67.4M | 59.0M | 49.0M | 26.1M | 20.8M | 15.7M |
| 總資產 | 926M | 911M | 808M | 802M | 731M | 808M | 796M | 728M | 686M | 639M | 618M | 572M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 100M | 119M | 141M | 124M | 95.1M | 119M | 99.6M | 90.3M | 96.8M | 95.3M | 88.9M | 67.2M |
| 股東權益 | 826M | 792M | 666M | 678M | 636M | 690M | 697M | 638M | 589M | 544M | 529M | 505M |
| 負債比 | 10.8% | 13.1% | 17.5% | 15.5% | 13.0% | 14.7% | 12.5% | 12.4% | 14.1% | 14.9% | 14.4% | 11.8% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | 12.8M | – | – | −6.7M-176% | – | – | – | 8.9M | – | – | −1.3M |
| 資本支出 | – | 9.7M | – | – | 8.4M | – | – | – | 11.7M | – | – | 3.8M |
| 自由現金流 | – | 3.1M | – | – | −15.1M+433% | – | – | – | −2.8M | – | – | −5.1M |
| 折舊攤銷 | 4.6M | 5.1M | 3.7M | 3.4M | 3.0M | 2.4M | 1.9M | 1.4M | 839K | 800K | 700K | 593K |
| 買回庫藏股 | – | 0.00 | – | – | 75.0M | – | – | – | 0.00 | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | 1.5% | – | – | -7.5% | – | – | – | -1.7% | – | – | -4.0% |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
業務分部2025 年度 · 912M
| Operating | 912M | 100.0% | +13.6% |
|---|
地區2025 年度 · 912M
| 美國 | 872M | 95.6% | +13.1% |
|---|---|---|---|
| 美國以外 | 39.9M | 4.4% | +25.6% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 912M | +13.6% | 145M | 15.9% | 4.89 | 78.5M |
| FY2024 | 803M | +28.5% | 53.5M | 6.7% | 1.75 | 91.1M |
| FY2023 | 625M | +53.2% | −21.2M | -3.4% | -0.72 | 1.0M |
| FY2022 | 408M | +74.7% | −44.9M | -11.0% | -1.60 | 2.5M |
| FY2021 | 233M | +102.3% | −42.0M | -18.0% | -1.54 | −24.8M |
| FY2020 | 115M | +40.6% | −57.2M | -49.6% | -2.19 | −55.5M |
| FY2019 | 82.1M | +62.2% | −33.2M | -40.5% | -1.40 | −35.6M |
| FY2018 | 50.6M | – | −21.8M | -43.1% | -1.50 | −18.9M |